PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
A synthetic peptide fraction of the naturally occurring protein thymosin beta-4.
WHAT DOES IT DO?
Promotes rapid cell migration and tissue repair, drastically reducing systemic inflammation.
HOW DO I USE IT?
Administered subcutaneously, almost exclusively stacked alongside BPC-157.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
NO VERIFIED OPERATORS FOUND DEPLOYING THIS PROTOCOL.